A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Eilean Therapeutics
National Cancer Institute (NCI)
University of Turin, Italy
University of Washington
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
MPN Research Foundation
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Constellation Pharmaceuticals
Hangzhou GluBio Pharmaceutical Co., Ltd.
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
AbbVie
University Health Network, Toronto
Astex Pharmaceuticals, Inc.
Fox Chase Cancer Center
City of Hope Medical Center
University of Nebraska
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Rutgers, The State University of New Jersey
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
University of Utah
Eli Lilly and Company
Wake Forest University Health Sciences
European Organisation for Research and Treatment of Cancer - EORTC
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
California Cancer Consortium
UNC Lineberger Comprehensive Cancer Center
Traws Pharma, Inc.
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center